This book provides a comprehensive overview of difficult decisions encountered within endocrine surgery. Brief uniformly formatted chapters are devoted to answering specific questions relevant to a range of topics across endocrine surgery based upon detailed analysis of available evidence.Topics covered include clinical decision analysis, decision making from the surgeons and patients perspective, using surgery as opposed to observation for papillary thyroid microcarcinoma, and the use of parathyroid cryopreservation.
Difficult Decisions in Endocrine Surgery: An Evidence-Based Approach features a wealth of information on ideal approaches for making clinical decisions in selected clinical situations. It is an important and timely resource for all endocrine surgical trainees, fellows, practitioners, educators, and healthcare providers involved in the management of these patients.
Recenzijas
This book provides up-to-date recommendations in clinical decision making for common clinical scenarios in endocrine surgery where the recommended management strategy is not always straightforward. It provides a well-organized summary of current literature with easy-to-follow tables summarizing pertinent data from the studies used to support the authors' recommendations. It is an excellent resource for endocrine surgeons and trainees to maintain/develop an evidence-based practice. (Anna C Beck, Doody's Book Reviews, February, 2019)
Evidence-based Medicine and the GRADE Approach.- Clinical Decision
Analysis.- Decision Making from the Surgeons Perspective.- Decision Making
from the Patients Perspective.- Surgery Versus Active Surveillance for
Papillary Thyroid Microcarcinoma.- Prospective Screening Protocol for FNMTC
Family Members: Ultrasound Versus Physical Examination.- Operative Management
Versus Observation for Thyroid Nodules Larger than 4 cm with Benign
Cytology.- Lobectomy Versus Total Thyroidectomy for Follicular
Microcarcinomas.- Initial Total Thyroidectomy Versus Lobectomy with
Intraoperative Frozen Section for Thyroid Nodules that are Suspicious for
PTC.- Primary Repair Versus No Repair for Transected Recurrent Laryngeal
Nerve.- Surgery Versus Observation for Papillary Thyroid
Microcarcinoma.- First-line Therapy for Anaplastic Thyroid Cancer: Operation
Versus Medical Management.- Same-Day Versus Overnight Inpatient Surgery for
Total Thyroidectomy.- Prophylactic Versus Selective Central Neck Dissection
in Pediatric Papillary Thyroid Cancer.- Subtotal Parathyroidectomy Versus
Total Parathyroidectomy with Autotransplantation for Patients with MEN-1 and
Primary Hyperparathyroidism.- Four-Gland Exploration versus 4D Computed
Tomography in Patients with Nonlocalized Primary Hyperparathyroidism.- Lymph
Node Dissection Versus No Lymph Node Dissection for Parathyroid
Cancer.- Early Versus Late Parathyroidectomy for Tertiary (Posttransplant)
Hyperparathyroidism.- Observation Versus Surgery for Pregnant Patients with
Primary Hyperparathyroidism.- Four-gland Exploration Versus Focused
Parathyroidectomy for Hyperparathyroidism Jaw Tumor Syndrome.- Long-Term
Success of Surgery for Primary Hyperparathyroidism: Intraoperative
Parathyroid Hormone Versus Four-Gland Exploration.- The Evidence For and
Against Parathyroid Cryopreservation: Should We Continue to Promote
Parathyroid Cryopreservation?.- Should Antibiotic Prophylaxis Be Given Prior
to Thyroidectomy or Parathyroidectomy?.- The Value of Intraoperative
Parathyroid Hormone Monitoring in Primary Hyperparathyroidism Cases that are
Localized.- Transperitoneal Versus Retroperitoneal Laparoscopic
Adrenalectomy.- Bilateral Adrenalectomy Versus Medical Management for
Cushings Syndrome with Bilateral Adrenal Hyperplasia.- Routine Screening for
Primary Hyperaldosteronism in Hypertensive Patients: Yes or No?.- Routine
Glucose Monitoring in Postoperative Pheochromocytoma Patients: Yes or
No?.- Surgical Versus Nonsurgical Management of Malignant
Pheochromocytoma.- Alpha Blocker Versus Calcium Channel Blocker for
Pheochromocytoma.- Surgical Versus Nonsurgical Therapy for Recurrent
Adrenocortical Carcinoma.- Resection Versus Observation for Adrenal Gland
Metastasis.- Routine Versus Selective Adrenal Vein Sampling for Primary
Aldosteronism.- Surgery Versus Observationfor Asymptomatic Nonfunctioning
Pancreatic Neuroendocrine Tumors.- Routine Lymph Node Dissection Versus
Duodenal Inspection Alone for the Treatment of Multiple Endocrine Neoplasia
Type 1 Patients with Hypergastrinemia.- Resection Versus Chemotherapy for
Metastatic Neuroendocrine Tumors of the Pancreas.- Observation Versus Surgery
for Nonlocalized Insulinoma.
Dr. Peter Angelos is a highly regarded surgeon with extensive experience in surgery of the thyroid, parathyroid, and adrenal glands. He is particularly adept in treating endocrine cancers, including thyroid, parathyroid, and adrenocortical cancers and islet cell tumors of the pancreas. Dr. Angelos also has extensive expertise in medical ethics, and serves as associate director of the University of Chicago MacLean Center for Clinical Medical Ethics. Dr. Raymon H. Grogan is a nationally respected board certified surgeon practising in Houston, Texas with a particular interest in Endocrine Surgery. He is the co-author of several national guidelines on endocrine surgery. He is also a pioneer of several novel techniques for operating on the thyroid and parathyroid and is one of only a handful of specialists on Transoral Endocrine Surgery in the USA. In 2017 he was awarded the prestigious Paul LoGerfo Research Grant from the American Association of Endocrine Surgeonsto study the relationship between the human microbiome and thyroid disease.
